Cargando…
PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery
Numerous human disorders can benefit from targeted, intravenous (IV) drug delivery. Polymeric nanoparticles have been designed to undergo systemic circulation and deliver their therapeutic cargo to target sites in a controlled manner. Poly(lactic‐co‐glycolic) acid (PLGA) is a particularly promising...
Autores principales: | Sheffey, Violet V., Siew, Emily B., Tanner, Eden E. L., Eniola‐Adefeso, Omolola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035064/ https://www.ncbi.nlm.nih.gov/pubmed/35032406 http://dx.doi.org/10.1002/adhm.202101536 |
Ejemplares similares
-
Dual Coating of Chitosan and Albumin Negates the Protein Corona-Induced Reduced Vascular Adhesion of Targeted PLGA Microparticles in Human Blood
por: Lopez-Cazares, Genesis, et al.
Publicado: (2022) -
IgA and IgM protein primarily drive plasma corona‐induced adhesion reduction of PLGA nanoparticles in human blood flow
por: Sobczynski, Daniel J., et al.
Publicado: (2017) -
Selective Blood Cell Hitchhiking in Whole Blood with Ionic Liquid-Coated PLGA Nanoparticles to Redirect Biodistribution After Intravenous Injection
por: Hamadani, Christine M., et al.
Publicado: (2023) -
Shear Stress Modulation of IL-1β-Induced E-Selectin Expression in Human Endothelial Cells
por: Huang, Ryan B., et al.
Publicado: (2012) -
Pathogens: the plight of plants
por: Henderson, Catherine, et al.
Publicado: (2004)